Strigari Lidia, Arcangeli Giorgio, Arcangeli Stefano, Benassi Marcello
Laboratory of Medical Physics and Expert Systems, Regina Elena Institute, Rome, Italy.
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1454-60. doi: 10.1016/j.ijrobp.2008.07.024. Epub 2008 Nov 5.
To describe the radiation-induced acute rectal toxicity (ART) using a modified Lyman-Kutcher-Burman normal tissue complication probability model and parameters set, taking into account the overall treatment time.
A total of 160 patients underwent three-dimensional conformal radiotherapy to the prostate and seminal vesicles and were randomized to receive 80 Gy in 40 fractions within 8 weeks (Group A) or 62 Gy in 20 fractions within 5 weeks, 4 d/wk (Group B). An additional 52 patients (Group C) underwent intensity-modulated radiotherapy with a hypofractionation schedule consisting of 56 Gy, delivered in 16 fractions (4/wk) of 3.5 Gy. Patients were followed for ART weekly during treatment. The overall treatment time, rectal dose-volume histograms, and ART status, defined as Radiation Therapy Oncology Group Grade 2 or greater gastrointestinal toxicity, were used to determine the modified Lyman-Kutcher-Burman model parameters. The m and n values were obtained from the cohort, and the tolerance doses for 50% complication probability for uniform irradiation [TD(50)(1)(k)] were obtained for each fractionation schedule indicated with k.
Of 212 patients treated with localized prostate radiotherapy, 65 developed Grade for > or = 1 week during treatment. The m and n value was 0.17 and 0.08, respectively. The TD(50)(1)(k) parameter was 79, 62.5, and 53 Gy, respectively for Group A, B, and C.
The optimized modified Lyman-Kutcher-Burman normal tissue complication probability model allowed us to describe the ART data from conventional and hypofractionated regimens, using the dose-volume histograms and overall treatment time. This model could prove useful in designing hypofractionation schedules to reduce the incidence of ART.
使用改良的莱曼-库彻-伯曼正常组织并发症概率模型及参数集描述辐射诱导的急性直肠毒性(ART),同时考虑总治疗时间。
总共160例患者接受了前列腺和精囊的三维适形放疗,并随机分为两组,A组在8周内分40次给予80 Gy,B组在5周内分20次给予62 Gy,每周4天。另外52例患者(C组)接受调强放疗,采用大分割方案,分16次(每周4次)给予56 Gy,每次3.5 Gy。治疗期间每周对患者进行ART随访。使用总治疗时间、直肠剂量体积直方图以及定义为放射治疗肿瘤学组2级或更高胃肠道毒性的ART状态来确定改良的莱曼-库彻-伯曼模型参数。从队列中获得m和n值,并针对每种标记为k的分割方案获得均匀照射下50%并发症概率的耐受剂量[TD(50)(1)(k)]。
在212例接受局部前列腺放疗的患者中,65例在治疗期间出现≥1周的≥2级毒性。m和n值分别为0.17和0.08。A、B、C组的TD(50)(1)(k)参数分别为79、62.5和53 Gy。
优化后的改良莱曼-库彻-伯曼正常组织并发症概率模型使我们能够利用剂量体积直方图和总治疗时间来描述来自常规和大分割方案的ART数据。该模型在设计大分割方案以降低ART发生率方面可能有用。